Related Experiment Video
Updated: Feb 17, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
THBD sequence variants potentially related to recurrent pregnancy loss
Paula Quintero-Ronderos1, Eric Mercier2,3, Jean-Christophe Gris2,3
1Center For Research in Genetics and Genomics-CIGGUR, GENIUROS Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24 N° 63C, -69, Bogotá, Colombia.
A specific mutation in the THBD gene (thrombin, thrombomodulin) may be linked to recurrent pregnancy loss (RPL). This finding could lead to new diagnostic tools for RPL.
Area of Science:
- Genetics
- Reproductive Medicine
- Molecular Biology
Background:
- Recurrent pregnancy loss (RPL) affects many women, often with unknown causes (idiopathic RPL).
- The THBD gene, encoding the thrombin receptor on endothelial cells, is a potential candidate gene for RPL due to its biological roles.
- Identifying genetic factors in RPL is crucial for understanding its etiology and developing diagnostic markers.
Purpose of the Study:
- To investigate the role of the THBD gene in the etiology of recurrent pregnancy loss.
- To identify potential genetic markers for RPL within the THBD gene.
- To explore the association between THBD gene mutations and RPL.
Main Methods:
- Sequencing of the complete coding region of the THBD gene in 262 patients with RPL.
- Bioinformatics analysis to identify mutations and assess their significance.
- Screening of control populations to evaluate the mutation's prevalence.
Main Results:
- A specific mutation, THBD-p.Trp153Gly, was identified and suggested to be associated with RPL.
- Bioinformatics analysis and control screening provided strong evidence for this association.
- The identified mutation warrants further investigation for its role in RPL.
Conclusions:
- The THBD-p.Trp153Gly mutation is a potential contributor to recurrent pregnancy loss.
- This mutation may serve as a molecular marker for the diagnosis or prognosis of RPL.
- Further functional studies are required to validate these findings and their clinical utility.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Probability Laws
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Teratogenicity
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...